Ligand profile
UFJ
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_03495 — Histone deacetylase superfamily protein
Identifiers
Database identifiers and provenance.
- Ligand ID
UFJ- PDB
6wyq- UniProt (similar protein)
F8W4B7- Target protein
- KP13_03495
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 78.4
- −1 ≤ LogP ≤ 5 3.08
- MW ≤ 500 Da 390.2
- LogP ≤ 5 3.08
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 78.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cc(ccc1NC(=O)CCCCCCC(=O)NO)Ic1cc(ccc1NC(=O)CCCCCCC(=O)NO)I
InChI=1S/C14H19IN2O3/c15-11-7-9-12(10-8-11)16-13(18)5-3-1-2-4-6-14(19)17-20/h7-10,20H,1-6H2,(H,16,18)(H,17,19)InChI=1S/C14H19IN2O3/c15-11-7-9-12(10-8-11)16-13(18)5-3-1-2-4-6-14(19)17-20/h7-10,20H,1-6H2,(H,16,18)(H,17,19)
BYVHZKAHBXINPL-UHFFFAOYSA-NBYVHZKAHBXINPL-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00850
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand UFJ →
- PDB RCSB structure 6wyq →
- UniProt UniProt F8W4B7 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “UFJ”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03495.
PDB 45
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 55
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).